Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 1, 1993 - Issue 3
1
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Reversible Inhibition of Inducible, but Not Constitutive, Nitric Oxide Synthase by NG -Nitro-L-Arginine in Rat Aorta

, &
Pages 141-145 | Received 02 Oct 1993, Published online: 13 Jul 2009
 

Abstract

The interactions between L-arginine, the source of nitric oxide formation, and N G-nitro-L-arginine (L-NOARG), an inhibitor of nitric oxide synthase were examined in isolated rat aorta. Carbachol induced endothelium-dependent relaxation was used to study the constitutive form of the enzyme, whereas the loss of contraction tonicity to phenylephrine following incubation of endothelium free rings with interleukin 1 was used to investigate the smooth muscle inducible form. L-NOARG is a potent inhibitor of the two types of the enzyme in the rat aorta. However, the effects of L-NOARG on the constitutive (endothelial) vascular NO synthase were partially prevented, but not reversed, by L-arginine. In contrast, L-arginine fully reversed the action of L-NOARG on the smooth muscle inducible form of NO synthase. The selective reversibility of L-NOARG on the inducible, by comparison with the constitutive form of nitric oxide synthase present in the vasculature, may represent a limitation in the use of this type of compounds in the treatment of the systemic arterial hypotension observed during septic shock.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.